welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposis
In a randomized clinical chemoprevention trial, a combination of celecoxib and diflouromethylornithine resulted in a nonsignificant benefit among patients with familial adenomatous polyposis when adenoma count in a defined area was used as the primary endpoint. However, the combination was well tolerated, and a secondary measure of adenoma burden using a video-based global assessment showed a significant incremental benefit.
expertly curated content related to this topic
-
Significantly Increased Pregnancy Rates After Laparoscopic Restorative Proctocolectomy: A Cross-sectional StudyOBJECTIVE: To assess the impact of a la...
-
National Cancer InstituteAlthough cancer has plagued the world fo...
-
MD Anderson Cancer CenterClinical Trial Center Patient Resourc...
-
Ohio State University HospitalsPatient Resources: The Ja...
-
Guide to Fighting Colon Polyps: How to Prevent Colon Polyps Naturally With FoodFrom garlic and turmeric to foods that c...
-
Laparoscopic Assisted Restorative Proctocolectomy for Familial Adenomatous Polyposishttps://www.youtube.com/watch?v=aguzeZIx...